Join us for a welcome address from Governor Matt Meyer.

Delaware’s longstanding leadership in industrial production has positioned the state to lead the next revolution in advanced manufacturing: making cutting-edge biopharmaceutical products at scale. In this session, global industry, investment and scientific leaders will explore the technological breakthroughs, workforce development imperatives and national security stakes at play in this unfolding new “space race” for our state and nation.

Artificial intelligence (AI) is dramatically reshaping the discovery and development of new medical technologies and therapies – ushering in a future of predictive, personalized, and preventative medicine. Across Delaware’s life science ecosystem, AI is accelerating drug discovery, enhancing diagnostic accuracy and improving patient care. We’ll hear how Delaware researchers are deploying this powerful technology and the technical and ethical challenges involved in navigating this immensely complex and exciting terrain.

Biomaterials have immense potential for transforming the way we live – with applications ranging from dynamic medical solutions to more sustainable agricultural systems. The session will highlight Delaware’s leading efforts to leverage these technologies across food, energy and medicine, and how synthetic biology is rapidly accelerating development of a new generation of “smart” biomaterials.

For more than a century, Delaware has been the premier global corporate venue thanks to a business-friendly environment, attractive tax advantages and our renowned Court of Chancery. The country’s top experts on Delaware’s unique legal and business assets will discuss what makes the First State the still-undisputed First Choice for incorporation and investment – including, importantly, for emerging and established life science enterprises.

Details coming soon!

Details coming soon!